Lie‐Ju Hwang

523 total citations
23 papers, 430 citations indexed

About

Lie‐Ju Hwang is a scholar working on Pulmonary and Respiratory Medicine, Cardiology and Cardiovascular Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lie‐Ju Hwang has authored 23 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 6 papers in Cardiology and Cardiovascular Medicine and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lie‐Ju Hwang's work include Pulmonary Hypertension Research and Treatments (13 papers), Glaucoma and retinal disorders (3 papers) and Ocular Surface and Contact Lens (3 papers). Lie‐Ju Hwang is often cited by papers focused on Pulmonary Hypertension Research and Treatments (13 papers), Glaucoma and retinal disorders (3 papers) and Ocular Surface and Contact Lens (3 papers). Lie‐Ju Hwang collaborates with scholars based in United States, United Kingdom and Belgium. Lie‐Ju Hwang's co-authors include J. David Curb, Richard Benfante, Cecil M. Burchfiel, Beatriz L. Rodríguez, Dan S. Sharp, Kamal Masaki, Jean‐Luc Vachiéry, William D. Spotnitz, John A. Jane and Robert J. Goldberg and has published in prestigious journals such as Circulation, American Journal of Epidemiology and CHEST Journal.

In The Last Decade

Lie‐Ju Hwang

23 papers receiving 417 citations

Peers

Lie‐Ju Hwang
B. Kutkuhn Germany
Attilio Losito Italy
Tamer Şakacı Türkiye
Linda M. Dansby United States
Ho Cheol Song South Korea
Begoña Laíz Spain
Uğur Küçük Türkiye
Antonio De Pascalis Italy
Fernando F. Corrales‐Medina United States
Serkan Bulur Türkiye
B. Kutkuhn Germany
Lie‐Ju Hwang
Citations per year, relative to Lie‐Ju Hwang Lie‐Ju Hwang (= 1×) peers B. Kutkuhn

Countries citing papers authored by Lie‐Ju Hwang

Since Specialization
Citations

This map shows the geographic impact of Lie‐Ju Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lie‐Ju Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lie‐Ju Hwang more than expected).

Fields of papers citing papers by Lie‐Ju Hwang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lie‐Ju Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lie‐Ju Hwang. The network helps show where Lie‐Ju Hwang may publish in the future.

Co-authorship network of co-authors of Lie‐Ju Hwang

This figure shows the co-authorship network connecting the top 25 collaborators of Lie‐Ju Hwang. A scholar is included among the top collaborators of Lie‐Ju Hwang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lie‐Ju Hwang. Lie‐Ju Hwang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Charles‐Schoeman, Christina, Ryan DeMasi, Hernán Valdez, et al.. (2019). Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long‐Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis. Arthritis & Rheumatology. 71(9). 1450–1459. 63 indexed citations
2.
Li, Zhanguo, Yi Liu, Huji Xu, et al.. (2018). Efficacy and Safety of Tofacitinib in Chinese Patients with Rheumatoid Arthritis. Chinese Medical Journal. 131(22). 2683–2692. 27 indexed citations
3.
Dhaun, Neeraj, Jean‐Luc Vachiéry, Raymond L. Benza, et al.. (2014). Endothelin antagonism and uric acid levels in pulmonary arterial hypertension: Clinical associations. The Journal of Heart and Lung Transplantation. 33(5). 521–527. 30 indexed citations
4.
Cappelleri, Joseph C., Lie‐Ju Hwang, Jack Mardekian, & Marko A. Mychaskiw. (2012). Assessment of measurement properties of peak VO2in children with pulmonary arterial hypertension. BMC Pulmonary Medicine. 12(1). 54–54. 6 indexed citations
5.
Simonneau, Gérald, et al.. (2012). Incidence of subdural hematoma in patients with pulmonary arterial hypertension (PAH) in two randomized controlled clinical trials. 40. 941. 3 indexed citations
6.
7.
Webb, David J., et al.. (2011). Sildenafil (SIL) reduces serum creatinine (SCr) in patients with pulmonary arterial hypertension (PAH): Relationship to clinical outcomes. European Respiratory Journal. 38(Suppl 55). p2281–p2281. 1 indexed citations
8.
Sandoval, Julio, Adam Torbicki, Rogério Souza, et al.. (2011). Safety and efficacy of sitaxsentan 50 and 100 mg in patients with pulmonary arterial hypertension. Pulmonary Pharmacology & Therapeutics. 25(1). 33–39. 29 indexed citations
9.
10.
11.
12.
Cappelleri, Joseph C., Lie‐Ju Hwang, Gary Layton, et al.. (2010). Assessment Of Measurement Properties Of Peak VO2 In Children With Pulmonary Arterial Hypertension. A4848–A4848. 2 indexed citations
13.
Trocmé, Stefan D., et al.. (2010). The Role of Benzalkonium Chloride in the Occurrence of Punctate Keratitis: A Meta-Analysis of Randomized, Controlled Clinical Trials. Annals of Pharmacotherapy. 44(12). 1914–1921. 12 indexed citations
14.
Mychaskiw, Marko A., Lie‐Ju Hwang, & Jack Mardekian. (2010). Evaluation Of Sildenafil Treatment On Functional Health Status In Patients With Pulmonary Arterial Hypertension. A3336–A3336. 1 indexed citations
15.
Varma, Rohit, et al.. (2009). Assessing the Efficacy of Latanoprost vs Timolol Using an Alternate Efficacy Parameter: The Intervisit Intraocular Pressure Range. American Journal of Ophthalmology. 148(2). 221–226. 7 indexed citations
16.
Varma, Rohit, et al.. (2008). Inter-visit Intraocular Pressure Range: An Alternative Parameter for Assessing Intraocular Pressure Control in Clinical Trials. American Journal of Ophthalmology. 145(2). 336–342. 23 indexed citations
17.
Burchfiel, Cecil M., Ellen Bloom Marcus, Dan S. Sharp, et al.. (1996). Characteristics associated with rapid decline in forced expiratory volume. Annals of Epidemiology. 6(3). 217–227. 43 indexed citations
18.
Hwang, Lie‐Ju. (1994). [8] Impact of variance function estimation in regression and calibration. Methods in enzymology on CD-ROM/Methods in enzymology. 240. 150–170. 6 indexed citations
19.
Benfante, Richard, Lie‐Ju Hwang, Kamal Masaki, & J. David Curb. (1994). To What Extent Do Cardiovascular Risk Factor Values Measured in Elderly Men Represent Their Midlife Values Measured 25 Years Earlier? A Preliminary Report and Commentary From the Honolulu Heart Program. American Journal of Epidemiology. 140(3). 206–216. 26 indexed citations
20.
Glasheen, William P., Thomas L. Matthew, Steven L. Gonias, et al.. (1992). Effects of antifibrinolytic agents on the life span of fibrin sealant. Journal of Surgical Research. 53(4). 402–407. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Kutkuhn Breakdown of academic impact, for papers by Attilio Losito Breakdown of academic impact, for papers by Tamer Şakacı Breakdown of academic impact, for papers by Linda M. Dansby Breakdown of academic impact, for papers by Ho Cheol Song Breakdown of academic impact, for papers by Begoña Laíz Breakdown of academic impact, for papers by Uğur Küçük Breakdown of academic impact, for papers by Antonio De Pascalis Breakdown of academic impact, for papers by Fernando F. Corrales‐Medina Breakdown of academic impact, for papers by Serkan Bulur
Rankless by CCL
2026